United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 1 minute read Pharma Industry News Lannett gets FDA nod for clinical trial of biosimilar insulin glargine Lannett Company has been given clearance from the US Food and Drug Administration (FDA) to proceed with a… bySrinathJanuary 22, 2022